President Donald Trump is preparing an executive order outlining a “favoured nations clause”, where US prices will reflect those in the country paying the least for their medicines. Trump recently made the announcement in a press briefing outside the White House, more than two years after promises to tackle high drug prices had been a
The Trump administration for the first time will require pharmaceutical companies to include the price of prescription drugs in television advertisements if the cost exceeds $35 per month. Announced on Wednesday by Alex M. Azar II, the health and human services secretary, it is the most visible action the administration has taken so far to
With gene therapies becoming a hot growth area, CDMOs are figuring out how to get a bigger piece of the market. Thermo Fisher Scientific decided to buy its way in, agreeing to pay $1.7 billion to get viral vector producer Brammer Bio. The cash deal, slated to close by the end of the second quarter, will see Waltham,
Drug companies could come under increased pressure to lower prices in the US, after the opposition Democrat party won control over the lower house in midterm elections. All the seats in the House of Representatives and a third of the seats in the Senate were up for grabs in the vote seen as a referendum
In a quarterly filing, the New York-based Big Pharma player said that its “preparations are well advanced to make the changes necessary to meet EU legal requirements after the U.K. is no longer a member state, especially in the regulatory, manufacturing and supply chain areas,” so that it can ensure a continuity of supply in
